Presentation TCT 2012 TWENTE 2-Year: A Prospective, Randomized Trial of Everolimus-Eluting vs. Zotarolimus-Eluting Stents Presenter: Clemens von Birgelen October 25, 2012
Presentation TCT 2012 IVUS-Guided PCI: From Stent Sizing to Predicting Thrombosis and Restenosis Presenter: Gary Mintz October 25, 2012
Presentation TCT 2012 Dynamic Obstruction: Mechanisms and Implications for Treatment Presenter: Carey Kimmelstiel October 25, 2012
Presentation TCT 2012 DCB Cost-Effectiveness Analysis: What Results Must Be Seen for Success in the United States? Presenter: Duane Pinto October 25, 2012
Presentation TCT 2012 What Is FFR, and How Is It Different from Other Indices? Presenter: William Fearon October 25, 2012
Presentation TCT 2012 First-in-Man Results with a Novel Nanoparticle-Based Sirolimus-Coated Balloon in Coronary In-Stent Restenosis Lesions (Concept Medical) Presenter: Suhas Lele October 25, 2012
Presentation TCT 2012 Case Review 3: How to Decide About a Second Clip for DMR Presenter: Richard Smalling October 25, 2012
Presentation TCT 2012 Debate: Transradial Access Should Be the Default Access Site in STEMI Patients! Presenter: Jennifer Tremmel October 25, 2012
Presentation TCT 2012 The European TAVR “Test Track”: After 5 Years, Have TAVR Use Patterns Drifted Out of Control? Presenter: Nicolo Piazza October 25, 2012